Variablesa | Aspirin versus warfarin | p value* | |
---|---|---|---|
Aspirin (n = 23) | Warfarin (n = 33) | ||
Age, years | 72.2 ± 8.6 | 74.2 ± 8.3 | 0.389 |
Female, n (%) | 11 (47.8) | 17 (51.5) | 0.786 |
Clinical Profiles | |||
CHADS2 | 3.2 ± 0.9 | 3.5 ± 0.8 | 0.232 |
CHA2DS2-VASc | 4.4 ± 1.3 | 4.9 ± 1.2 | 0.238 |
NIHSS, initial | 6.4 ± 6.2 | 5.6 ± 6.0 | 0.613 |
mRS, initial | 2.3 ± 1.7 | 2.5 ± 1.7 | 0.669 |
Laboratory Data | |||
White blood cell, × 103/μl | 7.8 ± 2.7 | 7.5 ± 3.2 | 0.716 |
Hematocrit, % | 37.0 ± 6.3 | 37.4 ± 5.7 | 0.803 |
Platelet, ×103/μl | 192.8 ± 44.1 | 219.9 ± 59.1 | 0.068 |
PT, % | 93.1 ± 12.0 | 85.0 ± 12.5 | 0.051 |
aPTT, second | 27.1 ± 7.6 | 30.7 ± 18.1 | 0.371 |
D-dimer, mg/L | 2.4 ± 3.6 | 2.4 ± 2.7 | 0.959 |
Albumin, g/dL | 5.6 ± 8.8 | 5.2 ± 7.2 | 0.854 |
Total protein, g/dL | 6.6 ± 0.8 | 6.7 ± 0.8 | 0.479 |
Creatinine, mg/dL | 0.8 ± 0.3 | 1.3 ± 2.4 | 0.296 |
eGFR, mL/min/1.73m2 | 84.7 ± 19.0 | 85.1 ± 17.8 | 0.940 |
Total cholesterol, mg/dL | 153.1 ± 30.2 | 155.3 ± 28.0 | 0.776 |
Triglyceride, mg/dL | 95.2 ± 39.8 | 90.4 ± 36.3 | 0.638 |
High density lipoprotein, mg/dL | 47.2 ± 13.9 | 47.5 ± 14.2 | 0.951 |
HbA1c, % | 5.9 ± 0.4 | 6.0 ± 0.5 | 0.763 |
UACR, mg/g | 114.8 ± 116.8 | 160.8 ± 203.8 | 0.334 |
Homocysteine, μmol/L | 16.2 ± 4.6 | 17.5 ± 13.1 | 0.654 |